NEW YORK - October 18 - Celera Genomics has signed The Weizmann Institute of Science in Israel, the California Institute of Technology, and The Institute for Genomic Research as subscribers to its database , the Rockville, Md., company announced Wednesday.
Each institution has signed a multi-year subscription to Celera Discovery System, which provides Web-based access to Celera’s database of human, mouse, and drosophila genomic information.
The financial terms of the agreements were not disclosed. Celera has previously stated that academic subscribers pay between $6,000 and $15,000 per scientist for access to its database.
" We are pleased that Celera's expanding genomic databases and related proprietary software can now be accessed by these three renowned, international institutions," Craig Venter, Celera's president and chief scientific officer, said in a statement. " Having access to this information should enable researchers at these institutions to make important discoveries and possible advances in the field of medicine."
The other publicly disclosed academic subscribers to Celera’s database include Howard Hughes Medical Institute, The University of Texas Southwestern Medical Center at Dallas, The University of Cincinnati, Ohio State University, The Australian National Health and Medical Research Council,and Vanderbilt University.
Additionally, several pharmaceutical companies pay between $5 and $15 million each to access Celera's database through custom portals at their facilities.